- Design of precise third-line therapy for gastric cancer: target or chemotherpy?
-
Cho JY
- KMID: 1776450
- Korean J Intern Med.
- 2013 May;28(3):297-299.
- doi: 10.3904/kjim.2013.28.3.297
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer
-
Kim JH, Lee YC
- KMID: 782915
- Korean J Gastroenterol.
- 2007 Sep;50(3):207-209.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Analysis of Treatment of Aggressive Fibromatosis Using Oral Methotrexate Chemotherapy
-
Yoon GW, Kim JD, Chung SH
- KMID: 1794733
- Clin Orthop Surg.
- 2014 Dec;6(4):439-442.
- doi: 10.4055/cios.2014.6.4.439
BACKGROUND: Aggressive fibromatosis is a rare but invasive tumor infiltrating widely between fascia and muscle fibers. It has a high tendency to be locally recurrent despite complete resection. Effectiveness of... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide
-
Ohe M, Hashino S
- KMID: 1776464
- Korean J Intern Med.
- 2013 May;28(3):377-379.
- doi: 10.3904/kjim.2013.28.3.377
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
-
Takekuma M, Kuji S, Tanaka A, Takahashi , Abe M, Hirashima
- KMID: 2160804
- J Gynecol Oncol.
- 2015 Jul;26(3):185-192.
- doi: 10.3802/jgo.2015.26.3.185
OBJECTIVE: The concept of platinum sensitivity and cross-resistance among platinum agents are widely known in the management of recurrent ovarian cancer. The aim of this study was to evaluate two... -
- CITED
-
- Close
- SHARE
-
- Close
- Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
-
Martin JY, Urban RR, Liao JB, Goff BA
- KMID: 2374249
- J Gynecol Oncol.
- 2016 Sep;27(5):e47.
- doi: 10.3802/jgo.2016.27.e47
OBJECTIVE: Bevacizumab was recently approved by the US Food and Drug Administration for use in recurrent platinum resistant epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
-
Lee M, Kim SW, Nam EJ, Cho H, Kim JH, Kim YT, Kim S
- KMID: 2070217
- Yonsei Med J.
- 2014 Nov;55(6):1664-1671.
- doi: 10.3349/ymj.2014.55.6.1664
PURPOSE: To investigate chemosensitivity with an adenosine triphosphate-based chemotherapy response assay in patients with epithelial ovarian or peritoneal cancer according to tumor histology, grade, and disease status. MATERIALS AND METHODS: One... -
- CITED
-
- Close
- SHARE
-
- Close
- Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer
-
Lee MA, Byun JH, Shim BY, Woo IS, Kang JH, Hong YS, Lee KS, Choi MG, Chang SK, Oh ST, Choi SI, Lee DS
- KMID: 1782231
- Korean J Intern Med.
- 2005 Sep;20(3):205-209.
- doi: 10.3904/kjim.2005.20.3.205
BACKGROUND: Irinotecan, in combination with 5-fluorouracil (5-FU) and a high dose of leucovorin (LV), known as FOLFIRI regimen, has shown activity in recurrent or metastatic colorectal cancer. Therefore, we evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Paclitaxel and Cisplatin Combination Chemotherapy for the Treatment of Metastatic or Recurrent Gastric Cancer: a Multicenter Phase II Study
-
Shin SJ, Chun SH, Kim KO, Kim MK, Lee KH, Hyun MS, Bae SH, Ryoo HM, Do YR, Kwon KY, Song HS
- KMID: 1718035
- Korean J Intern Med.
- 2005 Jun;20(2):135-140.
- doi: 10.3904/kjim.2005.20.2.135
BACKGROUND: Although many treatments for advanced gastric cancer have been developed, only poor treatment results have generally been obtained. We performed a prospective study on the combination chemotherapy of paclitaxel... -
- CITED
-
- Close
- SHARE
-
- Close
- Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
-
Lee JH, Kim SH, Oh SY, Lee S, Lee H, Lee HJ, Kim HJ
- KMID: 1776453
- Korean J Intern Med.
- 2013 May;28(3):314-321.
- doi: 10.3904/kjim.2013.28.3.314
BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
-
Kang H, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG
- KMID: 1782020
- J Korean Med Sci.
- 2009 Oct;24(5):945-950.
- doi: 10.3346/jkms.2009.24.5.945
The aim of this trial was to investigate the efficacy and toxicity of combination chemotherapy with etoposide and ifosfamide (ETI) in the management of heavily pretreated recurrent or persistent epithelial... -
- CITED
-
- Close
- SHARE
-
- Close
- ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkins Lymphoma: A Single Center Experience
-
Park SH, Kim S, Ko OB, Koo JE, Lee D, Jeong YP, Huh J, Kim SB, Kim SW, Lee JL, Suh C
- KMID: 759841
- Korean J Intern Med.
- 2006 Sep;21(3):159-164.
- doi: 10.3904/kjim.2006.21.3.159
BACKGROUND: The ESHAP chemotherapy regimen, that is, the combination of the etoposide, methylprednisolone, high-dose cytarabine and cisplatin, has been shown to be active against relapsing or refractory non-Hodgkin's lymphoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer
-
Kang SH, Kim JI, Goh PG, Hwang SW, Kwon DS, Nam KW, Kang HM, Kang YS, Moon HS, Kim SH, Seong JK, Lee BS, Jeong HY
- KMID: 782906
- Korean J Gastroenterol.
- 2007 Sep;50(3):157-163.
BACKGROUND/AIMS: The purpose of this study was to investigate the efficacy and safety of 'docetaxel-5-FU-cisplatin' combination chemotherapy as a first-line treatment in patients with metastatic or recurrent gastric cancer. ... -
- CITED
-
- Close
- SHARE
-
- Close
